Heidelberg University
Heidelberg, 69115, Germany
NCT Number: NCT02988453
A feasibility and pilot trial to investigate the feasibility of a newly manualized psychotherapy "Mentalization-Based Training for Adolescents with Conduct Disorder (MBT-CD)"
Looking for future studies?
Notify Me11 year–18 year
All sexes
Interventional
Not applicable
Heidelberg, 69115, Germany
Background: Conduct Disorder is a severe and complex mental disorder with the highest incidence in adolescence. Previous studies have shown that family-oriented interventions are effective in the treatment of Conduct Disorder. However, most therapies focus rather on symptom management and less on etiological causes without inclusion of the family in the therapeutic process. Previous research has linked specific symptoms of Conduct Disorder with deficits in mentalization ability. Mentalization is the ability to perceive one's own and other's behavior as the product of affective and cognitive mental states. Low or missing mentalization abilities are regarded as a risk factor for the development and chronification of Conduct Disorder.
Aims: The study aims to investigate the feasibility of a newly manualized psychotherapy "Mentalization-Based Training for Adolescents with Conduct Disorder (MBT-CD)" that strives to decrease symptoms associated with Conduct Disorder by increasing mentalization in adolescents and their families.
Methods: The study is feasibility and piolot trial, carried out in Heidelberg (Germany), and Mainz (Germany). Adolescents aged between 11-18, who meet the DSM-5 criteria for Conduct Disorder will receive MBT-CD. Times of measurement: t0 (Screening), T1 (Baseline, at the beginning of therapy), T2 (3 months after the beginning of therapy), T3 (at the end of therapy, after 6 months), T4 (follow-up, after 9 months).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MBT-CD is a disorder-specific modification of MBT, initially developed for patients with Borderline Personality Disorder. It is a manualized and psychodynamically oriented psychotherapy with the aim to increase the mentalization capacity of adolescents in close relationships. The therapy consists of 2 psychoeducational group sessions, 30 individual therapy sessions and 10 family sessions. The average duration of therapy is 6 months.
Time frame: Change from baseline in SCID-II at 12 months (at the end of therapy)
Time frame: Change from baseline in STAB at 6 months
Time frame: Change from baseline in STAB at 12 months (at the end of therapy)
Time frame: Change from baseline in STAB at 18 months (follow-up)
Time frame: Change from baseline in RPQ at 6 months
Time frame: Change from baseline in RPQ at 12 months (at the end of therapy)
Time frame: Change from baseline in RPQ at 18 months (follow-up)
Time frame: Change from baseline in GAF at 12 months (at the end of therapy)
Time frame: Change from baseline in CGI-SI at 12 months (at the end of therapy)
Time frame: Change from baseline in LoPF-QA at 12 months (at the end of therapy)
Time frame: Change from baseline in LoPF-QA at 18 months (follow-up)
Time frame: Change from baseline in RFQ at 12 months (at the end of therapy)
Time frame: Change from baseline in RFQ at 18 months (follow-up)
Time frame: Change from baseline in MASC at 12 months (at the end of therapy)
Time frame: Change from baseline in TGT at 12 months (at the end of therapy)
Time frame: Change from baseline in SHT at 12 months (at the end of therapy)
Time frame: Change from baseline in AAT at 12 months (at the end of therapy)
Time frame: Change from baseline in SCL-90R at 12 months (at the end of therapy)
Time frame: Change from baseline in SIPA at 12 months (at the end of therapy)
Time frame: Change from baseline in SIPA at 18 months (follow-up)
Time frame: after 12 months (at the end of therapy)
Time frame: after 12 months (at the end of therapy)
Cost-effectiveness will be measured by participation in training/school, rehospitalization, internment
Time frame: Change from baseline in WAI at 6 months
Treatment related variable (moderator)
Time frame: Change from baseline in WAI at 12 months (at the end of therapy)
Treatment related variable (moderator)
Time frame: Change from baseline in ECR-R at 12 months (at the end of therapy)
Treatment related variable (moderator)
Time frame: Change from baseline in ERQ at 12 months (at the end of therapy)
Treatment related variable (moderator)
Time frame: Change from baseline in ERQ at 18 months (follow-up)
Treatment related variable (moderator)
Time frame: Change from baseline in ZKE at 12 months (at the end of therapy)
Treatment related variable (moderator)
Time frame: Change from baseline in MINI at 12 months (at the end of therapy)
Treatment related variable (moderator)
Time frame: only baseline assessment
Treatment related variable (moderator)
Time frame: only baseline assessment
Treatment related variable (moderator)
Time frame: only baseline assessment
Treatment related variable (moderator)
Time frame: only baseline assessment
Treatment related variable (moderator)
Heidelberg University
Other
Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD): A Feasibility and Pilot Study
Acronym: MBT-CD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06301516
Attention Deficit and Disruptive Behavior Disorders, Callous-Unemotional Traits
Richmond, Virginia, United States
View Trial DetailsNCT06032520
Aberrant Motor Behavior in Dementia, Aggression
Utrecht, Netherlands
View Trial DetailsNCT05535387
Attention Deficit and Disruptive Behavior Disorders, Conduct Disorder
Springfield, Oregon, United States
View Trial DetailsNCT04168684
Anxiety Disorders, Attention Deficit and Disruptive Behavior Disorders
Newark, Delaware, United States
View Trial Details